Tim Kutzkey Purchases 315,457 Shares of Surrozen (NASDAQ:SRZN) Stock

Surrozen, Inc. (NASDAQ:SRZN - Get Free Report) Director Tim Kutzkey acquired 315,457 shares of the business's stock in a transaction on Thursday, November 13th. The stock was acquired at an average price of $12.65 per share, with a total value of $3,990,531.05. Following the transaction, the director owned 962,718 shares in the company, valued at approximately $12,178,382.70. The trade was a 48.74% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.Surrozen Stock PerformanceShares of NASDAQ SRZN traded down $0.58 during trading on Tuesday, reaching $15.54. The company had a trading volume of 100,264 shares, compared to its average volume of 92,641. Surrozen, Inc. has a 52 week low of $5.90 and a 52 week high of $18.17. The business's 50 day moving average price is $13.51 and its 200-day moving average price is $11.11. The stock has a market cap of $133.18 million, a PE ratio of -0.70 and a beta of 0.62. Surrozen (NASDAQ:SRZN - Get Free Report) last issued its earnings results on Friday, November 7th. The company reported ($3.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.17) by ($2.44). Surrozen had a negative net margin of 2,909.10% and a negative return on equity of 4,055.04%. The business had revenue of $0.98 million during the quarter. Equities analysts anticipate that Surrozen, Inc. will post -8.49 earnings per share for the current year. Hedge Funds Weigh In On SurrozenA number of hedge funds have recently added to or reduced their stakes in SRZN. Adage Capital Partners GP L.L.C. grew its position in Surrozen by 37.1% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 88,653 shares of the company's stock worth $1,034,000 after acquiring an additional 24,000 shares during the last quarter. Driehaus Capital Management LLC acquired a new stake in shares of Surrozen during the first quarter valued at about $2,390,000. Stonepine Capital Management LLC boosted its stake in shares of Surrozen by 108.3% during the first quarter. Stonepine Capital Management LLC now owns 285,782 shares of the company's stock valued at $3,332,000 after purchasing an additional 148,582 shares in the last quarter. RA Capital Management L.P. grew its holdings in shares of Surrozen by 140.3% during the first quarter. RA Capital Management L.P. now owns 679,130 shares of the company's stock worth $7,919,000 after purchasing an additional 396,550 shares during the last quarter. Finally, Vivo Capital LLC acquired a new position in shares of Surrozen in the first quarter valued at approximately $3,032,000. Institutional investors own 66.57% of the company's stock. Analysts Set New Price TargetsSeveral brokerages recently commented on SRZN. Weiss Ratings reiterated a "sell (d-)" rating on shares of Surrozen in a report on Wednesday, October 8th. Lifesci Capital upgraded Surrozen to a "strong-buy" rating in a research note on Thursday, November 13th. Finally, Wall Street Zen raised Surrozen to a "sell" rating in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $38.50.Get Our Latest Report on SRZNAbout Surrozen (Get Free Report)Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.Further ReadingFive stocks we like better than SurrozenWhich Wall Street Analysts are the Most Accurate?Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?Why Are Stock Sectors Important to Successful Investing?Checkmate in the Cloud: ServiceNow's Shopping SpreeHow to start investing in penny stocksThe Contrarian Case for MSTR Amid MSCI Delisting DebacleThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Surrozen Right Now?Before you consider Surrozen, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surrozen wasn't on the list.While Surrozen currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here